Skip to main content
Jean Wright, MD, Radiation Oncology, Chapel Hill, NC

Jean Wright MD

Breast Cancer


Nominated Professor and Chair, University of North Carolina

Join to View Full Profile
  • 101 Manning DriveDepartment of Radiation OncologyChapel Hill, NC 27514

  • Phone+1 984-974-0400

Dr. Wright is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2004 - 2008
  • Greenwich Hospital/Yale University
    Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 2003 - 2004
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2003

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2013 - 2026
  • MD State Medical License
    MD State Medical License 2013 - 2025
  • NC State Medical License
    NC State Medical License 2024 - 2025
  • FL State Medical License
    FL State Medical License 2008 - 2014
  • NY State Medical License
    NY State Medical License 2004 - 2011
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • A New Era in Breast Cancer: How Patient Choice and Shared Decision-Making Is Transforming Treatment
    A New Era in Breast Cancer: How Patient Choice and Shared Decision-Making Is Transforming TreatmentMarch 8th, 2025
  • Adjuvant Tamoxifen Reduces 15-Year Risk of Recurrence in ‘Good Risk’ DCIS Without Radiation Therapy
    Adjuvant Tamoxifen Reduces 15-Year Risk of Recurrence in ‘Good Risk’ DCIS Without Radiation TherapyJanuary 10th, 2025
  • Tamoxifen Reduces Risk for Invasive Recurrence of DCIS
    Tamoxifen Reduces Risk for Invasive Recurrence of DCISDecember 13th, 2024
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: